Basket cover image
11 handpicked stocks

Top Stocks for Recessions

These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+1

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at मई 3

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

GILD

Gilead Sciences Inc.

GILD

Current price

$117.98

PG

Procter & Gamble Company, The

PG

Current price

$158.40

MDLZ

Mondelez International, Inc.

MDLZ

Current price

$62.66

About This Group of Stocks

1

Our Expert Thinking

When economic uncertainty looms, smart investors seek stability. These "Recession Proofers" have demonstrated resilience during previous downturns, providing steady performance even when markets struggle. They represent companies with business models designed to weather economic storms.

2

What You Need to Know

These companies come from sectors that typically maintain demand during recessions, such as discount retail, groceries, food and beverages, energy, utilities, and healthcare. Their steady revenue streams and proven stability can provide a safety net for your investment portfolio.

3

Why These Stocks

Each company in this group has been selected for its track record of resilience during economic contractions. They are industry leaders with robust business models, diversified revenue streams, and the ability to adapt to changing market conditions when times get tough.

Group Performance Snapshot

8 of 10

Stocks Rated Buy by Analysts

8 of 10 assets in this group are rated Buy by professional analysts.

1.6%

Group Growth

This group averaged a 1.6% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🛡️

Safety When It Matters Most

When markets get turbulent, these stocks have historically provided stability. They could be your portfolio's safeguard during economic uncertainty, potentially preserving value while others decline.

🔄

Recession-Resistant Revenue

These companies sell products and services people need regardless of economic conditions. While other businesses see declining sales during recessions, these tend to maintain steadier performance.

🧠

Smart Money Moves Here

Professional investors often shift toward these reliable performers when recession signals appear. Getting familiar with these stocks now could help you make informed decisions before everyone else catches on.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.